Mutational analysis of the estrogen receptor ligand-binding domain: Influence of ligand structure and stereochemistry on transactivation

被引:15
|
作者
Kohno, H
Bocchinfuso, WP
Gandini, O
Curtis, SW
Korach, KS
机构
[1] Lab. of Repro. and Devmtl. Toxicol., Natl. Inst. of Environ. Hlth. Sci., National Institutes of Health, Research Triangle Park, NC 27709
关键词
D O I
10.1677/jme.0.0160277
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The mouse estrogen receptor (mER) exhibits ligand stereochemical specificity for indenestrol A (IA), a stilbestrol estrogen. IA has a chiral C3 methyl group, and the mER preferentially binds the S-enantiomer (IA-S). resulting in elevated biological activity when compared with the IA-R enantiomer. To elucidate the mechanisms for this stereochemical recognition, we have constructed a series of mERs with individual amino acid substitutions at Met521, His528, Met532, and Val537. The abilities of yeast-expressed wild-type and mutant mERs to transactivate an estrogen-responsive reporter gene construct were measured in the presence of diethylstilbestrol (DES) and IA enantiomers. The concentration of IA-S required to induce half-maximal transactivation by wild-type mER was 10-fold lower than IA-R, which is attributed to the 15-fold greater binding affinity for IA-S. Wild-type mER displayed similar dose-response curves for IA-R and demethyl IA, which lacks a C3 methyl group, demonstrating that the presence and correct orientation of the C3 methyl group on the IA compound is required for high-affinity ligand binding and transcriptional activity. Each mutant exhibited a reduced preference for IA-S enantiomer with respect to transactivation, suggesting that this region of the mER functions in ligand stereochemical recognition and activation. A mutation at Met532 diminished DES- and IA-S-induced transactivation by 7.5-fold and 40-fold respectively, with minimal change on their binding affinity. These data suggest that Met532 is required for transactivation induced by the potent agonist, IA-S, and the M532G mutation effectively uncouples IA-S ligand binding from transactivation. Use of these stereochemically different ligands in combination with mutagenesis of the mER demonstrates that ligand structure could influence transactivation by specifically altering the conformation of the mER AF-2 region.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [31] Molecular modeling of the GABAc receptor ligand-binding domain
    Harrison, NJ
    Lummis, SCR
    JOURNAL OF MOLECULAR MODELING, 2006, 12 (03) : 317 - 324
  • [32] Molecular modeling of the GABAC receptor ligand-binding domain
    Neil J. Harrison
    Sarah C.R. Lummis
    Journal of Molecular Modeling, 2006, 12 : 317 - 324
  • [33] Structural analysis of the GR ligand-binding domain
    Egner, U
    RECENT ADVANCES IN GLUCOCORTICOID RECEPTOR ACTION, 2002, 40 : 341 - 356
  • [34] Folding and stability of the ligand-binding domain of the glucocorticoid receptor
    McLaughlin, SH
    Jackson, SE
    PROTEIN SCIENCE, 2002, 11 (08) : 1926 - 1936
  • [35] IDENTIFICATION OF A DOMAIN OF ET(A) RECEPTOR REQUIRED FOR LIGAND-BINDING
    ADACHI, M
    YANG, YY
    TRZECIAK, A
    FURUICHI, Y
    MIYAMOTO, C
    FEBS LETTERS, 1992, 311 (02) : 179 - 183
  • [36] MAPPING THE LIGAND-BINDING DOMAIN OF PDGF-RECEPTOR
    ELDRIDGE, W
    ROONEY, B
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1995, 23 (01) : S73 - S73
  • [37] The 2.7 Å structure of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor
    Brejc, K
    van Dijk, WJ
    Smit, AB
    Sixma, TK
    ION CHANNELS: FROM ATOMIC RESOLUTION PHYSIOLOGY TO FUNCTIONAL GENOMICS, 2002, 245 : 22 - 32
  • [38] Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor
    Smit, AB
    Brejc, K
    Syed, N
    Sixma, TK
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 81 - 92
  • [39] The molecular structure of the Toll-like receptor 3 ligand-binding domain
    Bell, JK
    Botos, I
    Hall, PR
    Askins, J
    Shiloach, J
    Segal, DM
    Davies, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) : 10976 - 10980
  • [40] Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids
    Ikura, Teikichi
    Ito, Nobutoshi
    VITAMIN D HORMONE, 2016, 100 : 117 - 136